Understanding genetics in focal epilepsy brain tissue
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study is looking at brain tissue from people with a specific type of epilepsy (Focal Cortical Dysplasia Type II). The goal is to understand what causes the seizures and how they develop, which may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of Focal Cortical Dysplasia Type IIA or IIB (either confirmed by a biopsy or strongly suspected from MRI and other scans).
- You are scheduled to receive epilepsy surgery to remove the affected brain area.
- You can attend appointments to give a blood sample and a nasal swab.
- You are able to provide written informed consent (or a parent/guardian can for you).
- No other medical condition that would make it hard to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
This study uses MRI and a special EEG to understand brain connections in people with specific types of epilepsy or genetic conditions like Angelman syndrome and Dup15q. It may help find better ways to treat these conditions.
This study is observing how the brain's connections and activity work in people with epilepsy. It uses MRI scans and EEG recordings to learn more about the condition, which may help improve future treatments.
This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.
This study uses PET, MRI, and EEG scans to learn more about epilepsy. It may help researchers understand how the brain works in people with epilepsy and in healthy volunteers.
This study tests a new “hybrid” type of electrodes placed inside the brain to better map where seizures start in people with difficult (drug-resistant) focal epilepsy. It may help doctors plan safer and more effective surgery, though it involves an invasive brain monitoring procedure.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.